Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]
Zavvar TS +13 more
europepmc +1 more source
Navigating care: understanding cancer patients' experiences with systemic radionuclide therapy. [PDF]
Starkbaum J +3 more
europepmc +2 more sources
Efficacy and Safety of Epidermal Radionuclide Therapy with <sup>188</sup>Re Resin in Patients with Nonmelanoma Skin Cancers: Long-Term Data from a Single Center. [PDF]
Castellucci P +8 more
europepmc +1 more source
Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]
Kolodziej M +29 more
europepmc +1 more source
Targeted radionuclide therapy [PDF]
openaire +1 more source
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]
Ferro-Flores G +5 more
europepmc +1 more source
Advances in PSMA-Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer. [PDF]
Wang J, Yuan H, Xu J, Yang C.
europepmc +1 more source
Atypical Metastatic Disease in Thyroid from Pancreatic Neuroendocrine Tumor and its Response to [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT): A Promising Therapeutic Option for Somatostatin Receptor Expressing Unusual Metastatic Sites [PDF]
Mali Madhava Reddy +2 more
openalex +1 more source

